Grants and Contributions:

Back to search
Agreement Number:
-
Agreement Value:
$765,000.00
Agreement Date:
Apr 1, 2018 - Mar 31, 2022
Description:
Design and Development of Brain Permeant Indoleamine-2,3-Dioxygenase Inhibitors
Organization:
Canadian Institutes of Health Research
Location:
Toronto, Ontario, CA M5G 2C4
Reference Number:
236-2017-2018-Q4-00663
Agreement Type:
Grant
Report Type:
Grants and Contributions
Additional Information:

Grant or Award spanning more than one fiscal year.
(2018-19 to 2021-22)

Recipient's Legal Name:
Weaver, Donald F
Research Organization:
University Health Network (Toronto)